Transcriptome profiling revealed that HRH2 and CREB5 expression were increased in viral hepatitis and NASH, confirming involvement of the pathway in disease progression across the major etiologies (Fig. 7a, b). The gene discussed is HRH2; the disease is metabolic dysfunction-associated steatohepatitis.